181 related articles for article (PubMed ID: 37845719)
1. Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.
Kautz-Freimuth S; Redaèlli M; Shukri A; Kentenich H; Simic D; Mildenberger V; Schmutzler R; Rhiem K; Stock S
BMC Med Inform Decis Mak; 2023 Oct; 23(1):223. PubMed ID: 37845719
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
[TBL] [Abstract][Full Text] [Related]
3. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
Kautz-Freimuth S; Redaèlli M; Rhiem K; Vodermaier A; Krassuski L; Nicolai K; Schnepper M; Kuboth V; Dick J; Vennedey V; Wiedemann R; Schmutzler R; Stock S
BMC Med Inform Decis Mak; 2021 Jun; 21(1):180. PubMed ID: 34090422
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review.
Krassuski L; Vennedey V; Stock S; Kautz-Freimuth S
BMC Med Inform Decis Mak; 2019 Aug; 19(1):154. PubMed ID: 31370837
[TBL] [Abstract][Full Text] [Related]
5. Predictors of knowledge and knowledge gain after decision aid use among women with BRCA1/2 pathogenic variants.
Lautz Z; Kautz-Freimuth S; Shukri A; Redaèlli M; Rhiem K; Schmutzler R; Stock S
Patient Educ Couns; 2024 Jul; 124():108248. PubMed ID: 38513456
[TBL] [Abstract][Full Text] [Related]
6. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial.
Metcalfe KA; Dennis CL; Poll A; Armel S; Demsky R; Carlsson L; Nanda S; Kiss A; Narod SA
Genet Med; 2017 Mar; 19(3):330-336. PubMed ID: 27584910
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation.
Ehrbar V; Urech C; Rochlitz C; Zanetti Dällenbach R; Moffat R; Stiller R; Germeyer A; Nawroth F; Dangel A; Findeklee S; Tschudin S
Hum Reprod; 2019 Sep; 34(9):1726-1734. PubMed ID: 31398258
[TBL] [Abstract][Full Text] [Related]
8. Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
Isselhard A; Töpper M; Berger-Höger B; Steckelberg A; Fischer H; Vitinius F; Beifus K; Köberlein-Neu J; Wiedemann R; Rhiem K; Schmutzler R; Stock S
Trials; 2020 Jun; 21(1):501. PubMed ID: 32513307
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Steenbeek MP; van Bommel MHD; Harmsen MG; Hoogerbrugge N; van Doorn HC; Keurentjes JHM; van Beurden M; Zweemer RP; Gaarenstroom KN; Penders CGJ; Brood-van Zanten MMA; Vos MC; Piek JM; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; IntHout J; de Hullu JA; Hermens RPMG
Gynecol Oncol; 2021 Nov; 163(2):371-377. PubMed ID: 34456057
[TBL] [Abstract][Full Text] [Related]
10. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.
Rini C; O'Neill SC; Valdimarsdottir H; Goldsmith RE; Jandorf L; Brown K; DeMarco TA; Peshkin BN; Schwartz MD
Health Psychol; 2009 Sep; 28(5):569-578. PubMed ID: 19751083
[TBL] [Abstract][Full Text] [Related]
12. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
[TBL] [Abstract][Full Text] [Related]
13. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
15. Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial.
Metcalfe KA; Pal T; Narod SA; Armel S; Shickh S; Buckley K; Walters ST; Brennenstuhl S; Kinney AY
Cancer Med; 2023 Sep; 12(17):18246-18257. PubMed ID: 37602539
[TBL] [Abstract][Full Text] [Related]
16. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
18. Decision Coaching for Healthy Women With BRCA1/2 Pathogenic Variants—Findings of the Randomized Controlled EDCP-BRCA Trial.
Stock S; Isselhard A; Shukri A; Kautz-Freimuth S; Redaèlli M; Berger-Höger B; Dikow N; Kiechle M; Köberlein-Neu J; Meisel C; Schmutzler R; Steckelberg A; van Mackelenbergh MT; Vitinius F; Wöckel A; Rhiem K
Dtsch Arztebl Int; 2024 Jun; (Forthcoming):. PubMed ID: 38629689
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1).
Kiechle M; Dukatz R; Yahiaoui-Doktor M; Berling A; Basrai M; Staiger V; Niederberger U; Marter N; Lammert J; Grill S; Pfeifer K; Rhiem K; Schmutzler RK; Laudes M; Siniatchkin M; Halle M; Bischoff SC; Engel C
BMC Cancer; 2017 Nov; 17(1):752. PubMed ID: 29126396
[TBL] [Abstract][Full Text] [Related]
20. Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
Pozzar RA; Seven M
J Genet Couns; 2024 Apr; 33(2):392-401. PubMed ID: 37328917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
